Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid

Journal of Investigative Dermatology

Volumn 116, Issue 5, 2001, Pages 702-712

  Westergaard, Majken ^a   Henningsen, Jeanette ^a   Svendsen, Morten Lyne ^b   Johansen, Claus ^b   Jensen, Uffe Birk ^c   Bolund, Lars ^c   Kragballe, Knud ^b   Schrøder, Henrik Daa ^a   Berge, Rolf Kristian ^d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

CD36; FAT; Involucrin; MAPK; PPARs; Transglutaminase 1

Indexed keywords

CD36 ANTIGEN; FATTY ACID DERIVATIVE; INVOLUCRIN; LIGAND; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; ROSIGLITAZONE; THIOACETIC ACID;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 17744392617     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01329.x     Document Type: Article

References (68)

1. Bastie C, Holst D, Gaillard D, Jehl-Pietri C, Grimaldi PA: Expression of peroxisome proliferator-activated receptor PPARδ promotes induction of PPARγ and adipocyte differentiation in 3T3C2 fibroblasts. J Biol Chem 274:21920-21925, 1999
2. Berger J, Leibowitz MD, Doebber TW, et al: Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects. J Biol Chem 274:6718-6725, 1999
3. Bishop-Bailey D, Hla T: Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ12,14-prostaglandin J2. J Biol Chem 274:17042-17048, 1999
4. Boukamp P, Petrussevska RT, Breitkreutz D, Homung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
5. Braissant O, Wahli W: Differential expression of peroxisome proliferator-activated receptor-α-β, and -γ during rat embryonic development. Endocrinology 139:2748-2754, 1998
6. Camp HS, Tafuri SR: Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J Biol Chem 272:10811-10816, 1997
7. Camp HS, Tafuri SR, Leff T: c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity. Endocrinology 140:392-397, 1999
8. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752, 1987
9. Chinetti G, Griglio S, Antonucci M, et al: Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273:25573-25580, 1998
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
11. Ellis CN, Varani J, Fisher GJ, et al: Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation. Arch Dermatol 136:609-616, 2000
12. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM Jr, Hajjar DP, Nicholson AC: Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ. J Lipid Res 41:688-696, 2000
13. Fisher JG, Voorhees JJ: Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013, 1996
14. Floyd EE, Jetten AM: Regulation of type I (epidermal) transglutaminase mRNA levels during squamous differentiation: down regulation by retinoids. Mol Cell Biol 9:4846-4851, 1989
15. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-Δ 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812, 1995
16. Froyland L, Madsen L. Sjursen W, et al: Effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart. J Lipid Res 38:1522-1534, 1997
17. Fuchs E: Epidermal differentiation: the bare essentials. J Cell Biol 111:2807-2814, 1990
18. Gandarillas A, Watt FM: c-Myc promotes differentiation of human epidermal stem cells. Genes Dev 11:2869-2882, 1997
19. Glass CK, Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 15:121-141, 2000
20. Hanley K, Jiang Y, Crumrine D, et al: Activators of the nuclear hormone receptors PPARα and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100:705-712, 1997
21. Hanley K, Jiang Y, He SS, et al: Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARα. J Invest Dermatol 110:368-375, 1998
22. Hanley K, Komuves LG, Bass NM, et al: Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol 113:788-795, 1999
23. Hanley K, Komuves LG, Ng DC, et al: Famesol stimulates differentiation in epidermal keratinocytes via PPARalpha. J Biol Chem 275:11484-11491, 2000a
24. Hanley K, Ng DC, He SS, et al: Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol 114:545-553, 2000b
25. Hansen JB, Petersen RK, Larsen BM, Bartkova J, Alsner J, Kristiansen K: Activation of peroxisome proliferator-activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation. J Biol Chem 274:2386-2393, 1999
26. Hansen JB, Zhang H, Rasmussen TH, Petersen RK, Flindt EN, Kristiansen K: Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J Biol Chem, 276:3175-3182, 2001
27. He TC, Chan TA, Vogelstein B, Kinzler KW: PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345, 1999
28. Helledie T, Antonius M, Sørensen RV, et al: Lipid-binding proteins modulate ligand-dependent transactivation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J Lipid Res 41:1740-1751, 2000
29. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T: Regulation of terminal differentiation of cultured mouse epidermal cells by 1alpha, 25-dihydroxyvitamin D3. Endocrinology 113:1950-1957. 1983
30. Hu E, Kim JB, Sarraf P, Spiegelman BM: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103, 1996
31. Imakado S, Bickenbach JR, Bundman DS, et al: Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 9:317-329, 1995
32. Itin PH, Pittelkow MR, Kumar R: Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology 135:1793-1798, 1994
33. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD: mRNA profiling of rat islet tumors reveals nkx 6,1 as a beta-cell-specific homeodomain transcription factor. J Biol Chem 271:18749-18758, 1996
34. Kawahito Y, Kondo M, Tsubouchi Y, et al: 15-Deoxy-Δ (12,14)-PGJ (2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 106:189-197, 2000
35. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 405:421-424, 2000
36. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771-774, 1992
37. Kliewer SA, Forman BM, Blumberg B, et al: Differential expression and activation of a family of mutine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359, 1994
38. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819, 1995
39. Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR: Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 111:429-433, 1998
40. Komuves LG, Hanley K, Lefebvre AM, et al: Stimulation of PPARα promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 115:353-360, 2000a
41. Komuves LG, Hanley K, Man MQ, Elias PM, Williams ML, Feingold KR: Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARα activators restores tissue homeostasis. J Invest Dermatol 115:361-367, 2000b
42. Lee SS, Pineau T, Drago J, et al: Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022, 1995
43. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956, 1995
44. Leibowitz MD, Fievet C, Hennuyer N, et al: Activation of PPARδ alters lipid metabolism in db/db mice. FEBS Lett 473:333-336, 2000
45. Lim H, Gupta RA, Ma WG, et al: Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev 13:1561-1574, 1999
46. Macklis JD, Sidman RL, Shine HD: Cross-linked collagen surface for cell culture that is stable, uniform, and optically superior to conventional surfaces. In Vitro Cell Dev Biol 21:189-194, 1985
47. Madsen L, Froyland L, Grav HJ, Berge RK: Upregulated delta 9-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: accumulation of a delta 9-desaturated metabolite of tetradecylthioacetic acid. J Lipid Res 38:554-563, 1997
48. Matsuura H, Adachi H, Smart RC, Xu X, Arata J, Jetten AM: Correlation between expression of peroxisome proliferator-activated receptor β and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol 147:85-92, 1999
49. Michel S, Courseaux A, Miquel C, et al: Determination of retinoid activity by an enzyme-linked immunosorbent assay. Anal Biochem 192:232-236, 1991
50. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63, 1983
51. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue-and inducer-specific manner. J Biol Chem 273:16710-16714, 1998
52. Mukherjee R, Strasser J, Jow L, Hoener P, Patemiti JR Jr, Heyman RA: RXR agonists activate PPARα-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol 18:272-276, 1998
53. Peters JM, Lee SS, Li W, et al: Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β (δ). Mol Cell Biol 20:5119-5128, 2000
54. Pillai S, Bikle DD: Epidermal vitamin D metabolism, function, and regulation. Adv Lipid Res 24:321-341, 1991
55. Rice RH, Green H: Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18:681-694, 1979
56. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S: Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 111:1116-1121, 1998
57. Rivier M, Castiel I, Safonova I, Ailhaud G, Michel S: Peroxisome proliferator-activated receptor-α enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 114:681-687, 2000
58. Ryle CM, Breitkreutz D, Stark HJ, Leigh IM, Steinert PM, Roop D, Fusenig NE: Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones. Differentiation 40:42-54, 1989
59. Saitou M, Sugai S, Tanaka T, Shimouchi K, Fuchs E, Narumiya S, Kakizuka A: Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 374:159-162, 1995
60. Schoonjans K, Staels B, Auwerx J: The peroxisome proliterator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109, 1996
61. Spydevold O, Bremer J: Induction of peroxisomal beta-oxidation in 7800 C1 Morris hepatoma cells in steady state by fatty acids and fatty acid analogues. Biochim Biophys Acta 1003:72-79, 1989
62. Su JL, Simmons CJ, Wisely B, Ellis B, Winegar DA: Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR. alpha-specific MAbs. Hybridoma 17:47-53, 1998
63. 2D3 and synthetic vitamin D3 analogues in a cell density-, calcium-and serum-dependent manner. Pharmacol Toxicol 80:49-56, 1997
64. Teumer J, Zezulak K, Green H: Measurement of specific mRNA content of keratinocytes of different sizes in relation to growth and differentiation. In: Leigh I, Lane B, Watt F, eds. The Keratinocyte Handbook. Cambridge, U.K.: Cambridge University Press, 1994:pp 235-242
65. Thacher SM, Rice RH: Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell 40:685-695, 1985
66. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252, 1998
67. Willson TM, Brown PJ, Stembach DD, Henke BR: The PPARs: from orphan receptors to drug discovery. J Med Chem 43:527-550, 2000
68. Xu HE, Lambert MH, Montana VG, et al: Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 397-403, 1999